Clinical Trial Update: Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection [Phase 4]

View source ↗

Summary

Phase 4 trial examining immune reconstitution as a determinant of adverse effects to new antiretroviral therapy in persons with advanced HIV infection; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: University of Cincinnati | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2022-08-10